Author Bozorgmehr, Farastuk
-
2016 | Report
9-year experience: Prophylactic cranial irradiation in extensive disease small-cell lung cancer
Bernhardt, D.; Adeberg, S.; Bozorgmehr, F.; Opfermann, N.; Hoerner-Rieber, J.; Repka, M.& Kappes, J. et al. (2016)
Details
-
2016 | Journal Article
Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation
Bernhardt, D.; Bozorgmehr, F.; Adeberg, S.; Opfermann, N.; von Eiff, D.; Rieber, J. & Kappes, J. et al. (2016)
Lung Cancer, 101 pp. 76-81. DOI: https://doi.org/10.1016/j.lungcan.2016.09.010
Details DOI PMID PMC
-
2017 | Journal Article
P2.05-025 9-Year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer
Bernhardt, D.; Adeberg, S.; Bozorgmehr, F.; Hoerner-Rieber, J.; Kappes, J.; Thomas, M. & Bischoff, H. et al. (2017)
Journal of Thoracic Oncology, 12(1) pp. S1045-S1046. DOI: https://doi.org/10.1016/j.jtho.2016.11.1460
Details DOI
-
2017 | Report
P17-2-jD Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy
Bernhardt, D.; Bozorgmehr, F.; Adeberg, S.; König, L.; Kappes, J.; Thomas, M.& Herth, F. et al. (2017)
Details
-
2017 | Journal Article
Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer
Bernhardt, D.; Adeberg, S.; Bozorgmehr, F.; Opfermann, N.; Hoerner-Rieber, J.; Repka, M. C & Kappes, J. et al. (2017)
Clinical Lung Cancer, 18(4) pp. e267-e271. DOI: https://doi.org/10.1016/j.cllc.2016.11.012
Details DOI PMID PMC
-
2017 | Journal Article
Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy
Bernhardt, D.; Adeberg, S.; Bozorgmehr, F.; Opfermann, N.; Hoerner-Rieber, J.; König, L. & Kappes, J. et al. (2017)
Journal of Neuro-Oncology, 134(1) pp. 205-212. DOI: https://doi.org/10.1007/s11060-017-2510-0
Details DOI PMID PMC
-
2018 | Journal Article
Outcome and prognostic factors in single brain metastases from small-cell lung cancer
Bernhardt, D.; Adeberg, S.; Bozorgmehr, F.; Opfermann, N.; Hörner-Rieber, J.; König, L. & Kappes, J. et al. (2018)
Strahlentherapie und Onkologie, 194(2) pp. 98-106. DOI: https://doi.org/10.1007/s00066-017-1228-4
Details DOI PMID PMC
-
2018 | Journal Article
EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer
Christopoulos, P.; Endris, V.; Bozorgmehr, F.; Elsayed, M.; Kirchner, M.; Ristau, J. & Buchhalter, I. et al. (2018)
International Journal of Cancer, 142(12) pp. 2589-2598. DOI: https://doi.org/10.1002/ijc.31275
Details DOI PMID PMC
-
2018 | Journal Article
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Bernhardt, D.; Aufderstrasse, S.; König, L.; Adeberg, S.; Bozorgmehr, F.; Christopoulos, P. & Shafie, R. A E. et al. (2018)
Cancer Management and Research, 10 pp. 6563-6569. DOI: https://doi.org/10.2147/CMAR.S180990
Details DOI PMID PMC
-
2018 | Journal Article
Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices
Bernhardt, D.; König, L.; Aufderstrasse, S.; Krisam, J.; Hoerner-Rieber, J.; Adeberg, S. & Bozorgmehr, F. et al. (2018)
Clinical Lung Cancer, 19(4) pp. 340-345. DOI: https://doi.org/10.1016/j.cllc.2017.12.004
Details DOI PMID PMC
-
2019 | Journal Article
Re-irradiation in locally recurrent lung cancer patients
Schlampp, I.; Rieber, J.; Adeberg, S.; Bozorgmehr, F.; Heußel, C. P.; Steins, M. & Kappes, J. et al. (2019)
Strahlentherapie und Onkologie, 195(8) pp. 725-733. DOI: https://doi.org/10.1007/s00066-019-01457-2
Details DOI PMID PMC
-
2019 | Journal Article |
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
Bozorgmehr, F.; Hommertgen, A.; Krisam, J.; Lasitschka, F.; Kuon, J.; Maenz, M. & Huber, P. E et al. (2019)
BMC Cancer, 19(1) pp. 1074. DOI: https://doi.org/10.1186/s12885-019-6205-0
Details DOI PMID PMC
-
2020 | Journal Article
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration Rates
Eichkorn, T.; Bozorgmehr, F.; Regnery, S.; Dinges, L. A.; Kudak, A.; Bougatf, N. & Weber, D. et al. (2020)
Frontiers in Oncology, 10 art. 586449. DOI: https://doi.org/10.3389/fonc.2020.586449
Details DOI PMID PMC
-
2020 | Journal Article |
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
von Eiff, D.; Bozorgmehr, F.; Chung, I.; Bernhardt, D.; Rieken, S. ; Liersch, S. & Muley, T. et al. (2020)
Journal of Thoracic Disease, 12(3) pp. 782-793. DOI: https://doi.org/10.21037/jtd.2019.12.74
Details DOI PMID PMC
-
2020 | Journal Article |
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
Rheinheimer, S.; Heussel, C.-P.; Mayer, P.; Gaissmaier, L.; Bozorgmehr, F.; Winter, H. & Herth, F. J. et al. (2020)
Cancers, 12(4) pp. 1046. DOI: https://doi.org/10.3390/cancers12041046
Details DOI PMID PMC
-
2020 | Journal Article |
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al. (2020)
BMC Cancer, 20(1). DOI: https://doi.org/10.1186/s12885-020-07264-8
Details DOI
-
2021 | Journal Article
Thoracic radiotherapy PLUS durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy: Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy—The TRADE-hypo trial.
Bozorgmehr, F.; Juergens, J.; Hammer-Hellmig, M.; Meyer Zum Bueschenfelde, C.; Classen, J.; Alt, J. & Stockinger, M. et al. (2021)
Journal of Clinical Oncology, 39(15_suppl) pp. TPS8585-TPS8585. DOI: https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS8585
Details DOI
-
2021 | Journal Article
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer
Bozorgmehr, F.; Kazdal, D.; Chung, I.; Kirchner, M.; Magios, N.; Kriegsmann, M. & Allgäuer, M. et al. (2021)
Frontiers in Oncology, 11 art. 640048. DOI: https://doi.org/10.3389/fonc.2021.640048
Details DOI PMID PMC
-
2022 | Journal Article
Thorakale Onkologie – frühe Stadien
Bozorgmehr, F.; Eichhorn, F.; Tufman, A.; Rieken, S. & Thomas, M. (2022)
Der Onkologe,. DOI: https://doi.org/10.1007/s00761-021-01092-6
Details DOI
-
2022 | Journal Article | Research Paper |
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
Bozorgmehr, F.; Christopoulos, P.; Chung, I.; Cvetkovic, J.; Feißt, M.; Krisam, J. & Schneider, M. A. et al. (2022)
BMC Cancer, 22(1) art. 1011. DOI: https://doi.org/10.1186/s12885-022-10074-9
Details DOI